RELN and Alzheimer disease: Overall, this analysis demonstrates several AD risk genes are regulated either by Apoer2 and/or by the Apoer2-ICD, implicating Apoer2 and its alternative splicing in AD pathogenesis and suggesting the Apoer2/Reelin is a rational target for possible AD therapies.